A Rare Pediatric Paratesticular Spindle Cell Rhabdomyosarcoma and Systematic Literature Review

Read full text
Authors: Gevara Arja, Omar Hammam Salloum, Jamal Jaber, Tala Jubah, Sumaya Alrjoub, Taghreed Imran, Asma Alrjoub, Ammar W M Hassouneh, Motaz A. Natsheh
Cited by: 1
References: 15

Abstract

Paratesticular rhabdomyosarcoma (RMS) is a rare malignancy, representing ~3% of all pediatric soft tissue tumors. The spindle cell subtype, a variant of embryonal RMS, is particularly uncommon but is typically associated with a favorable prognosis. We report the case of a 12-year-old boy who presented with a painless, progressively enlarging right inguinoscrotal mass. Imaging studies revealed a heterogeneous lesion without distant metastasis, and tumor markers were within normal limits. The patient underwent radical orchiectomy, and histopathology confirmed spindle cell RMS, with immunohistochemical positivity for myogenin and desmin. After completing treatment with the Children's Oncology Group (COG)-ARST0531 Vincristine, Actinomycin D, and Cyclophosphamide protocol, a retroperitoneal lymph node recurrence was detected 1 year later. Management consisted of surgical resection and escalated chemotherapy per the COG-ARST0431 protocol, with subsequent imaging showing no evidence of disease. This case demonstrates that despite a favorable histology, paratesticular spindle cell RMS carries a risk of late, regional recurrence, underscoring the necessity of vigilant long-term surveillance. We also performed a systematic literature review to contextualize our findings, focusing on clinical presentation, therapeutic strategies, and outcomes.

Fields of Study & Subjects

Sarcoma Diagnosis and Treatment Testicular diseases and treatments Neuroblastoma Research and Treatments

Publication details

Journal / source
Journal of Investigative Medicine High Impact Case Reports
Publisher
SAGE Publications
Volume
14
Pages
23247096251415447–23247096251415447
Publication date
1 January 2026
Language
EN